Viewing Study NCT04852692

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2026-02-07 @ 11:28 PM
Study NCT ID: NCT04852692
Status: TERMINATED
Last Update Posted: 2025-05-23
First Post: 2021-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants
Sponsor: Janssen Korea, Ltd., Korea
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Graft vs Host Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic View
None Ibrutinib View
None Retrospective View
None Prospective View